Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizationAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalDeferred TaxesDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsSales of Property, Plant and EquipmentSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Gains from Investment Securities (2016 - 2026)

Sanofi's Gains from Investment Securities history spans 15 years, with the latest figure at $41.0 million for Q1 2026.

  • On a quarterly basis, Gains from Investment Securities rose 532.83% to $41.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$242.9 million, a 53.22% decrease, with the full-year FY2025 number at -$409.7 million, down 4.77% from a year prior.
  • Gains from Investment Securities hit $41.0 million in Q1 2026 for Sanofi, up from -$121.1 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for SNY hit a ceiling of $100.1 million in Q4 2023 and a floor of -$1.6 billion in Q2 2023.
  • Historically, Gains from Investment Securities has averaged -$193.8 million across 5 years, with a median of -$8.8 million in 2024.
  • Biggest five-year swings in Gains from Investment Securities: tumbled 1456.83% in 2025 and later surged 532.83% in 2026.
  • Tracing SNY's Gains from Investment Securities over 5 years: stood at $35.7 million in 2022, then surged by 180.22% to $100.1 million in 2023, then tumbled by 202.52% to -$102.6 million in 2024, then decreased by 18.01% to -$121.1 million in 2025, then surged by 133.85% to $41.0 million in 2026.
  • Business Quant data shows Gains from Investment Securities for SNY at $41.0 million in Q1 2026, -$121.1 million in Q4 2025, and -$136.8 million in Q3 2025.